Ignite Creation Date:
2024-05-06 @ 1:10 AM
Last Modification Date:
2024-10-26 @ 10:59 AM
Study NCT ID:
NCT01740557
Status:
COMPLETED
Last Update Posted:
2023-08-31
First Post:
2012-11-30
Brief Title:
Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-21
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-30
First Submit QC Date:
December 3 2012
Study First Post Date:
2012-12-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2023-08-31
Last Update Post Date Type:
ACTUAL